Pricing Log in Create free account

Structure Therapeutics Inc. Sponsored ADR (GPCR) vs Intellia Therapeutics, Inc. (NTLA)

Structure Therapeutics Inc. Sponsored ADR and Intellia Therapeutics, Inc. are both Biotechnology companies. Structure Therapeutics Inc. Sponsored ADR and Intellia Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Structure Therapeutics Inc. Sponsored ADR has the higher net margin (0.00% vs −672.2%) and the lower return on invested capital (−1,371.8% vs −91.3%). Across the 13 metrics below, Structure Therapeutics Inc. Sponsored ADR leads on 9 and Intellia Therapeutics, Inc. on 4.

Valuation

Metric GPCR NTLA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 25.62 9.71
P/B 1.12 2.09 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 18.26 9.21
Earnings yield (14.35%) (29.42%) (33.15%)
Free cash flow yield (14.75%) (22.87%) (25.50%)

Profitability

Metric GPCR NTLA Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (711.66%) 0.00%
Net margin 0.00% (672.16%) 0.00%
Free cash flow margin 0.00% (585.82%) 0.00%
Return on equity (20.21%) (55.44%) (56.36%)
Return on assets (19.17%) (45.55%) (48.04%)
Return on invested capital (1,371.78%) (91.28%) 0.00%

Growth

Metric GPCR NTLA Biotechnology median
Revenue growth (TTM) — 12.58% 6.02%
EPS growth (last fiscal year) (2.47%) 27.43% 30.26%
Revenue growth, 5-year CAGR — 3.13% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GPCR NTLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 20.75 6.65 4.72
Net debt to EBITDA 8.27 1.06 0.96

Dividend

Metric GPCR NTLA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GPCR NTLA Biotechnology median
Market cap 1.58b 1.59b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack